Trial NCT04602065

View at ClinicalTrials.gov 
Org. Study IDs: CIBI318B201

Last trial update was posted on 2023-03-15

MeSH Interventions

Antibodies Antibodies, Bispecific

MeSH Conditions

Lymphoma Lymphoma, Extranodal NK-T-Cell Lymphoma, T-Cell Lymphoma, T-Cell, Peripheral

Other Conditions

Extranodal NK/T Cell Lymphoma, Nasal Type

Stopping Reasons

Due to the company's development strategy adjustment, Innovent Biologics has decided not to continue this study after consultation with investigators.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID